Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Weighted Average) (2016 - 2025)

Volitionrx filings provide 11 years of Shares Outstanding (Weighted Average) readings, the most recent being $36.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 40.5% to $36.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.3 million, a 40.5% increase, with the full-year FY2025 number at $36.3 million, up 40.5% from a year prior.
  • Shares Outstanding (Weighted Average) hit $36.3 million in Q4 2025 for Volitionrx, down from $48.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $87.9 million in Q3 2024 to a low of $539000.0 in Q4 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $52.8 million (2021), compared with a mean of $51.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 98.98% in 2022 and later skyrocketed 2895.52% in 2024.
  • Volitionrx's Shares Outstanding (Weighted Average) stood at $52.7 million in 2021, then tumbled by 98.98% to $539000.0 in 2022, then surged by 60.02% to $862500.0 in 2023, then skyrocketed by 2895.52% to $25.8 million in 2024, then skyrocketed by 40.5% to $36.3 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $36.3 million (Q4 2025), $48.0 million (Q3 2025), and $47.3 million (Q2 2025) per Business Quant data.